Results 1 to 10 of about 23,679 (284)

Importance of iron chelation therapy [PDF]

Thalassemia Reports, 2011
It is necessary to remember that today patients have different options of chelation treatment, as desferrioxamine, deferiprone and deferasirox are available. However, a patient has to be compliant with treatments.
A. Varoğlu
doaj   +4 more sources

Chelation therapy and autism [PDF]

BMJ, 2006
EDITOR—More children are being diagnosed as having autism, and there are currently no treatments based on aetiology.1 Consequently, a number of controversial, unproved, alternative treatments have arisen. The recent death of an autistic child after a medication error with intravenous chelation therapy has brought one purported aetiology based treatment
Yashwant Sinha, Natalie Silove, Katrina Williams   +2 more
openalex   +4 more sources

EDTA chelation therapy for cardiovascular disease: a systematic review [PDF]

BMC Cardiovascular Disorders, 2005
Background Numerous practitioners of both conventional and complementary and alternative medicine throughout North America and Europe claim that chelation therapy with EDTA is an effective means to both control and treat cardiovascular disease.
Wu Ping, Seely Dugald MR, Mills Edward J
doaj   +2 more sources

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia [PDF]

Frontiers in Pediatrics, 2022
Study backgroundThalassemia is the commonest genetic blood disorder in Malaysia which requires life-long blood transfusions. From a total of 7,984 thalassemia patients in Malaysia, adolescent age group account for the highest number of patients (2,680 ...
Rafaa Mohamed, Amir Hamzah Abdul Rahman, Farin Masra, Zarina Abdul Latiff   +3 more
doaj   +2 more sources

A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. [PDF]

Mediterranean Journal of Hematology and Infectious Diseases, 2023
. Objective: To evaluate the age at menarche and menstrual characteristics in patients with transfusion-dependent thalassemia (TDT) who started early chelation therapy (≤ 3 years) with a variety of chelating agents.
SALVATORE DI MAIO, VINCENZO DE SANCTIS, PIERLUIGI MARZUILLO, CHRISTOS KATTAMIS, SHAHINA DAAR, MEHERAN KARIMI, SAKI FOROUGH, ATANAS BANKEV, VALERIA KALEVA, SOTEROULA CHRISTOU, CARMELO FORTUGNO, POLYXENI DELAPORTA, ASHRAF T SOLIMAN , PLOUTARCHOS TZOULIS   +13 more
doaj   +2 more sources

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome [PDF]

Advances in Hematology, 2010
Iron chelation therapy is often used to treat iron overload in patients requiring transfusion of red blood cells (RBC). A 76-year-old man with MDS type refractory cytopenia with multilineage dysplasia, intermediate-1 IPSS risk, was referred when he ...
Maha A. Badawi, Linda M. Vickars, Jocelyn M. Chase, Heather A. Leitch   +3 more
doaj   +2 more sources

The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential [PDF]

Cancer Medicine
Background Despite significant therapeutic advancements in recent decades, colorectal cancer (CRC) continues to exhibit high rates of mortality and morbidity.
Gihani Vidanapathirana, Md Sajedul Islam, Sujani Gamage, Alfred K. Lam, Vinod Gopalan   +4 more
doaj   +2 more sources

Combination Therapies in Iron Chelation [PDF]

Thalassemia Reports, 2014
The availability of oral iron chelators and new non-invasive methods for early detection and treatment of iron overload, have significantly improved the life expectancy and quality of life of patients with β thalassemia major. However, monotherapy is not effective in all patients for a variety of reasons.
Raffaella Origa
openalex   +4 more sources

Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia [PDF]

Journal of Blood Medicine, 2022
Fatema Habbash,* Wegdan Al-Bati,* Howra Al-Hashim,* Maryam Aldossari,* Ahmed Alali, Khalid Alalyani, Zainab Al-Ebrahim, Nouf Hamed, Samma Eraqe, Ziyad Binayfan, Azzam Al Marri, Thamer Aljaber Department of Family and Community Medicine ...
Habbash F, Al-Bati W, Al-Hashim H, Aldossari M, Alali A, Alalyani K, Al-Ebrahim Z, Hamed N, Eraqe S, Binayfan Z, Al Marri A, Aljaber T   +11 more
doaj   +2 more sources

Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene [PDF]

Journal of Movement Disorders, 2022
Mutations in the manganese transporter gene SLC39A14 lead to inherited disorders of manganese metabolism. Chelation therapy with edetate calcium disodium (SLC39A14 deficiencyTA) is known to effectively reduce manganese deposition.
Jae-Hyeok Lee, Jin-Hong Shin
doaj   +2 more sources